| 12421235 |
Bridged tricyclic carbamoylpyridone compounds and uses thereof |
Hang Chu, Hongyan Guo, Lan Jiang, Jiayao Li, David W. Lin +4 more |
2025-09-23 |
|
| 12227520 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2025-02-18 |
|
| 12202842 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Lan Jiang, Darryl Kato +8 more |
2025-01-21 |
|
| 12187734 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2025-01-07 |
|
| 12162844 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2024-12-10 |
$252,679,000 |
| 12054496 |
Bridged tricyclic carbamoylpyridone compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Anna E. Hurtley, Lan Jiang +5 more |
2024-08-06 |
$110,474,000 |
| 12024528 |
Bridged tricyclic carbamoylpyridone compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Anna E. Hurtley, Lan Jiang +5 more |
2024-07-02 |
$457,639,000 |
| 11897892 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2024-02-13 |
$118,355,000 |
| 11667652 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Lan Jiang, Darryl Kato +8 more |
2023-06-06 |
$568,374,000 |
| 11643400 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2023-05-09 |
$305,124,000 |
| 11613546 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley +10 more |
2023-03-28 |
$310,764,000 |
| 11548902 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2023-01-10 |
$214,003,000 |
| 11548908 |
Heterobifunctional inhibitors of E-selectin and galectin-3 |
John L. Magnani, John M. Peterson, Arun K. Sarkar, Yusufbhai U. VOHRA |
2023-01-10 |
$3,253,000 |
| 11352329 |
HIV protease inhibitors |
Zhenhong R. Cai, Aesop Cho, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Salman Y. Jabri +5 more |
2022-06-07 |
$208,963,000 |
| 11110091 |
Modulators of toll-like receptors |
Manoj C. Desai, Randall L. Halcomb, Paul Hrvatin, Hon Chung Hui, Ryan McFadden +1 more |
2021-09-07 |
$428,322,000 |
| 11084832 |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +9 more |
2021-08-10 |
$462,351,000 |
| 10988451 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2021-04-27 |
$236,030,000 |
| 10800772 |
Therapeutic compounds |
Zhenhong R. Cai, Hongyan Guo, Mingzhe Ji, Haolun Jin, Amy S. Lee +5 more |
2020-10-13 |
$741,702,000 |
| 10774053 |
HIV protease inhibitors |
Zhenhong R. Cai, Aesop Cho, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Salman Y. Jabri +5 more |
2020-09-15 |
$253,208,000 |
| 10703733 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2020-07-07 |
$851,015,000 |
| 10647730 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2020-05-12 |
|
| 10172860 |
Modulators of toll-like receptors |
Manoj C. Desai, Randall L. Halcomb, Paul Hrvatin, Hon Chung Hui, Ryan McFadden +1 more |
2019-01-08 |
$217,992,000 |
| 9902741 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2018-02-27 |
$53,328,000 |
| 9879023 |
Therapeutic compounds |
Kerim Babaoglu, Michael L. Mitchell, Ryan McFadden, Paul A. Roethle, Lianhong Xu |
2018-01-30 |
$266,323,000 |
| 9840519 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2017-12-12 |
$29,601,000 |
